Amresh Kumar

Executive Officer at Grace Therapeutics

Capital raised by Grace Therapeutics

$15.0M+$15.0M latest round

1 Form D filing · first filed Feb 2025 · Princeton, NJ

CURRENT ROLE: Executive Officer
SECTOR: Biotech
COMPANY FILINGS: 1
TEAM ON FILE: 2
FOUNDED: —
30D INTEREST: 1 ↗

Career

1 company on file

Grace TherapeuticsBiotech · Princeton, NJsince Feb 2025

Executive Officer

Listed on Grace Therapeutics's Form D filings · VP of Program Management

Company filings

via EDGAR · Form D for Grace Therapeutics1

DateCompanyFormAmountRole on filing

Feb 10, 2025Grace TherapeuticsForm D+$15.0M—

Form DFeb 10, 2025 · Grace Therapeutics+$15.0Mnot a signer

Overview

Last filing Feb 10, 2025

Amresh Kumar is on file as Executive Officer at Grace Therapeutics in Princeton, NJ. Grace Therapeutics has 1 Form D filing on record, $15.0M raised in total. VP of Program Management

Teammates

Grace Therapeutics · 1

Prashant KohliChief Executive OfficerSigner

Products

Grace Therapeutics · 1

GTx-104IV Drug Therapy

GTx-104 is an intravenous infusion specifically designed for treating aneurysmal subarachnoid hemorrhage (aSAH), a rare and life-threatening condition characterized by bleeding on the surface of the brain. This product is currently in late-stage clinical development.